CD4 and tuberculosis: One of these is HIV which, in DR-TB programmatic settings (including Charles James), is typically clinically advanced (CD4 < 200 cells/mm3); frequently patients living with HIV are diagnosed with DR-TB when ART naïve or experiencing ART treatment failure [22, 23].